Find Clinical Trials | Cedars-Sinai

147 results found

Breast

Low-Dose Tamoxifen in Low-Risk, Early-Stage Breast Cancer

Hormone receptor-positive breast cancer is the most common type of breast cancer, and 5+ years of hormone therapy is the mainstay of the treatment. However, many patients experience side effects from the medications, and some ...

Lung

Amgen, 20230153, Ph 2, randomized, open-label, NSCLC, AMG193

Primary Objective: To characterize safety and efficacy of 2 dose levels of AMG 193 by investigator.

Leukemia, other

Venetoclax Plus Chemotherapy For Newly Diagnosed Acute Myeloid Leukemia

This study focuses on people who have a new diagnosis of acute myeloid leukemia (AML) who agreed to participate in the MyeloMATCH study and were matched to this treatment trial. The purpose of the study ...

Colon, Lung, Melanoma, Other Female Genital, Thyroid, Unknown Sites

Pierre Fabre Médicament, KN-8701/KIN2787CI101, Ph1/1b, open label, Solid Tumors, KIN-2787

2. Study Objectives 2.1. Part A Dose Escalation 2.1.1. Part A1: KIN-2787 Monotherapy Dose Escalation -The primary objectives of Part A1 are to determine the safety and tolerability of PO administration of KIN-2787 including DLTs in ...

Unknown Sites

Neoadjuvant Immunotherapy With Response-Adapted Treatment in Resectable Stage III/IV Cutaneous Squamous Cell Carcinoma

This study focuses on people who have advanced squamous cell skin cancer that can be removed with surgery. The purpose of the study is to determine whether giving an immunotherapy drug called cemiplimab before and ...